+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Opioids Market - Global Forecast 2026-2032- Product Image
Opioids Market - Global Forecast 2026-2032- Product Image
New

Opioids Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 188 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5977695
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The opioids market remains highly dynamic, shaped by evolving clinical needs, regulatory scrutiny, and shifting public health priorities. Senior leaders navigating this space must balance legitimate therapeutic demand, regulatory compliance, and operational resilience in response to fast-changing risks and opportunities.

Market Snapshot: Opioids Market Size and CAGR

The Opioids Market grew from USD 22.44 billion in 2025 to USD 23.37 billion in 2026. It is expected to continue growing at a CAGR of 4.21%, reaching USD 29.96 billion by 2032.

Scope & Segmentation

  • Opioid Types: Natural Opiates (e.g., Codeine, Morphine), Semi-Synthetic Opioids (e.g., Hydrocodone, Oxycodone), Synthetic Opioids (e.g., Fentanyl, Methadone)
  • Modes of Administration: Oral (capsules, tablets), Parenteral (intravenous, intramuscular), Transdermal systems
  • Clinical Applications: Acute and chronic pain management, anesthesia (general and regional), cough suppression
  • End-User Settings: Hospitals, clinics, home healthcare, research and academic institutes
  • Regions Covered: Americas, Europe, Middle East & Africa, Asia-Pacific
  • Technology Use: Abuse-deterrent formulations, digital health tools, prescription monitoring programs

Key Takeaways

  • Stakeholders are balancing pain management needs with efforts to deter diversion and misuse, as regulatory enforcement intensifies and public scrutiny persists.
  • Emerging technologies—including prescription monitoring and telehealth—are enabling precise oversight of prescribing practices and supporting evidence-based interventions.
  • Product portfolio strategies are evolving, with investment in abuse-deterrent formulations and research into non-opioid alternatives to reduce risks while maintaining access.
  • Regional disparities in regulatory frameworks and healthcare delivery require tailored strategies to address diverse access, safety, and operational challenges across global markets.
  • Collaboration across manufacturers, payers, and public health agencies drives integrated harm-reduction initiatives and supports the shift toward patient-centered pain management.

Tariff Impact

Recent U.S. tariff measures through 2025 have altered pharmaceutical supply chains for opioid products. Increased costs for active ingredients and finished formulations have prompted manufacturers to re-examine sourcing strategies, invest in nearshore or local production, and diversify supplier networks. Procurement teams and health systems are adjusting inventory management and renegotiating contracts to minimize price volatility and ensure access. These tariff-related shifts, combined with ongoing litigation and regulatory obligations, are accelerating consolidation within supply networks and encouraging investment in resilient manufacturing and distribution models.

Methodology & Data Sources

This report integrates regulatory filings, peer-reviewed studies, clinical guidelines, and data from supply chain documentation. Insights derive from structured interviews with clinicians, pharmacists, procurement leaders, and executives. Both qualitative and quantitative inputs were triangulated to validate trends, with scenario analysis stress-testing key conclusions.

Why This Report Matters

  • Enables executives to anticipate market shifts and regulatory developments shaping the opioid sector.
  • Supplies actionable segmentation insights supporting investment, product development, and operational planning.
  • Equips leaders with evidence-based recommendations to enhance safety, stakeholder alignment, and supply resilience.

Conclusion

Coordinated strategy and adaptive leadership are essential for maintaining therapeutic access while managing public health and regulatory risks. This report equips decision-makers with the analytical clarity needed to address the complexities of the opioids market and drive responsible, resilient outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Opioids Market, by Opioid Types
8.1. Natural Opiates
8.1.1. Codeine
8.1.2. Morphine
8.2. Semi-Synthetic Opioids
8.2.1. Hydrocodone
8.2.2. Oxycodone
8.3. Synthetic Opioids
8.3.1. Fentanyl
8.3.2. Methadone
9. Opioids Market, by Mode of Administration
9.1. Oral Administration
9.1.1. Capsules
9.1.2. Tablets
9.2. Parenteral Administration
9.2.1. Intramuscular
9.2.2. Intravenous
9.3. Transdermal Administration
10. Opioids Market, by Application
10.1. Anesthesia
10.1.1. General Anesthesia
10.1.2. Regional Anesthesia
10.2. Cough Suppression
10.3. Pain Management
10.3.1. Acute Pain
10.3.2. Chronic Pain
11. Opioids Market, by End-User
11.1. Healthcare Facilities
11.1.1. Clinics
11.1.2. Hospitals
11.2. Home Healthcare
11.3. Research Institutes
12. Opioids Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Opioids Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Opioids Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Opioids Market
16. China Opioids Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. AbbVie Inc.
17.6. Alvogen
17.7. Apotex Inc.
17.8. Biesterfeld SE
17.9. Daiichi Sankyo Company, Limited
17.10. Elite Pharmaceuticals, Inc.
17.11. Endo International plc
17.12. Fresenius SE & Co. KGaA
17.13. Hikma Pharmaceuticals PLC
17.14. Humanwell Healthcare (Group) Co., Ltd.
17.15. Indivior PLC
17.16. Johnson & Johnson Services, Inc.
17.17. Johnson Matthey Group
17.18. Kyowa Hakko Kirin Co. Ltd.
17.19. Mallinckrodt plc
17.20. Nutriband Inc.
17.21. Pfizer Inc.
17.22. Piramal Pharma Limited
17.23. Purdue Pharma L.P.
17.24. QuVa Pharma, Inc
17.25. SCA Pharma
17.26. Spectrum Chemical Mfg. Corp.
17.27. Teva Pharmaceutical Industries Ltd.
17.28. Tofigh Daru Research & Engineering Company
17.29. Verve HumanCare Laboratories
17.30. Viatris Inc.
List of Figures
FIGURE 1. GLOBAL OPIOIDS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL OPIOIDS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL OPIOIDS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL OPIOIDS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL OPIOIDS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL OPIOIDS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL OPIOIDS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL OPIOIDS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES OPIOIDS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA OPIOIDS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL OPIOIDS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL OPIOIDS MARKET SIZE, BY NATURAL OPIATES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL OPIOIDS MARKET SIZE, BY NATURAL OPIATES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL OPIOIDS MARKET SIZE, BY NATURAL OPIATES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL OPIOIDS MARKET SIZE, BY CODEINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL OPIOIDS MARKET SIZE, BY CODEINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL OPIOIDS MARKET SIZE, BY CODEINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL OPIOIDS MARKET SIZE, BY MORPHINE, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL OPIOIDS MARKET SIZE, BY MORPHINE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL OPIOIDS MARKET SIZE, BY MORPHINE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL OPIOIDS MARKET SIZE, BY HYDROCODONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL OPIOIDS MARKET SIZE, BY HYDROCODONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL OPIOIDS MARKET SIZE, BY HYDROCODONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL OPIOIDS MARKET SIZE, BY OXYCODONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL OPIOIDS MARKET SIZE, BY OXYCODONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL OPIOIDS MARKET SIZE, BY OXYCODONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL OPIOIDS MARKET SIZE, BY FENTANYL, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL OPIOIDS MARKET SIZE, BY FENTANYL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL OPIOIDS MARKET SIZE, BY FENTANYL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL OPIOIDS MARKET SIZE, BY METHADONE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL OPIOIDS MARKET SIZE, BY METHADONE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL OPIOIDS MARKET SIZE, BY METHADONE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL OPIOIDS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL OPIOIDS MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL OPIOIDS MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL OPIOIDS MARKET SIZE, BY TABLETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL OPIOIDS MARKET SIZE, BY TABLETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL OPIOIDS MARKET SIZE, BY TABLETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL OPIOIDS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL OPIOIDS MARKET SIZE, BY INTRAMUSCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL OPIOIDS MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL OPIOIDS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL OPIOIDS MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL OPIOIDS MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL OPIOIDS MARKET SIZE, BY TRANSDERMAL ADMINISTRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL OPIOIDS MARKET SIZE, BY TRANSDERMAL ADMINISTRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL OPIOIDS MARKET SIZE, BY TRANSDERMAL ADMINISTRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL OPIOIDS MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL OPIOIDS MARKET SIZE, BY ANESTHESIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL OPIOIDS MARKET SIZE, BY ANESTHESIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL OPIOIDS MARKET SIZE, BY GENERAL ANESTHESIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL OPIOIDS MARKET SIZE, BY GENERAL ANESTHESIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL OPIOIDS MARKET SIZE, BY GENERAL ANESTHESIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL OPIOIDS MARKET SIZE, BY REGIONAL ANESTHESIA, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL OPIOIDS MARKET SIZE, BY REGIONAL ANESTHESIA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL OPIOIDS MARKET SIZE, BY REGIONAL ANESTHESIA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL OPIOIDS MARKET SIZE, BY COUGH SUPPRESSION, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL OPIOIDS MARKET SIZE, BY COUGH SUPPRESSION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL OPIOIDS MARKET SIZE, BY COUGH SUPPRESSION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL OPIOIDS MARKET SIZE, BY ACUTE PAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL OPIOIDS MARKET SIZE, BY ACUTE PAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL OPIOIDS MARKET SIZE, BY ACUTE PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL OPIOIDS MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL OPIOIDS MARKET SIZE, BY CHRONIC PAIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL OPIOIDS MARKET SIZE, BY CHRONIC PAIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL OPIOIDS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL OPIOIDS MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL OPIOIDS MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL OPIOIDS MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL OPIOIDS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL OPIOIDS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL OPIOIDS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL OPIOIDS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL OPIOIDS MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL OPIOIDS MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL OPIOIDS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL OPIOIDS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL OPIOIDS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL OPIOIDS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS OPIOIDS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 100. AMERICAS OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2032 (USD MILLION)
TABLE 101. AMERICAS OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2032 (USD MILLION)
TABLE 102. AMERICAS OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 103. AMERICAS OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 104. AMERICAS OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 105. AMERICAS OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 106. AMERICAS OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 107. AMERICAS OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 108. AMERICAS OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
TABLE 109. AMERICAS OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 110. AMERICAS OPIOIDS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 111. AMERICAS OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 112. NORTH AMERICA OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 113. NORTH AMERICA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2032 (USD MILLION)
TABLE 114. NORTH AMERICA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2032 (USD MILLION)
TABLE 115. NORTH AMERICA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 116. NORTH AMERICA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 117. NORTH AMERICA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 118. NORTH AMERICA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 119. NORTH AMERICA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 120. NORTH AMERICA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 121. NORTH AMERICA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
TABLE 122. NORTH AMERICA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 123. NORTH AMERICA OPIOIDS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 124. NORTH AMERICA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 125. LATIN AMERICA OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. LATIN AMERICA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2032 (USD MILLION)
TABLE 127. LATIN AMERICA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2032 (USD MILLION)
TABLE 128. LATIN AMERICA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 129. LATIN AMERICA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 130. LATIN AMERICA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 131. LATIN AMERICA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 132. LATIN AMERICA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 133. LATIN AMERICA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 134. LATIN AMERICA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
TABLE 135. LATIN AMERICA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 136. LATIN AMERICA OPIOIDS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 137. LATIN AMERICA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 138. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 139. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2032 (USD MILLION)
TABLE 140. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2032 (USD MILLION)
TABLE 141. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 142. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 143. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 144. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 145. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 146. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 151. EUROPE OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 152. EUROPE OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2032 (USD MILLION)
TABLE 153. EUROPE OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2032 (USD MILLION)
TABLE 154. EUROPE OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 155. EUROPE OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 156. EUROPE OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 157. EUROPE OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 158. EUROPE OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 159. EUROPE OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. EUROPE OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
TABLE 161. EUROPE OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 162. EUROPE OPIOIDS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 163. EUROPE OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 164. MIDDLE EAST OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 165. MIDDLE EAST OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2032 (USD MILLION)
TABLE 166. MIDDLE EAST OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2032 (USD MILLION)
TABLE 167. MIDDLE EAST OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 168. MIDDLE EAST OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 169. MIDDLE EAST OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 170. MIDDLE EAST OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 171. MIDDLE EAST OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 172. MIDDLE EAST OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 173. MIDDLE EAST OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
TABLE 174. MIDDLE EAST OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 175. MIDDLE EAST OPIOIDS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 176. MIDDLE EAST OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 177. AFRICA OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. AFRICA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2032 (USD MILLION)
TABLE 179. AFRICA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2032 (USD MILLION)
TABLE 180. AFRICA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 181. AFRICA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 182. AFRICA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 183. AFRICA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 184. AFRICA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 185. AFRICA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 186. AFRICA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
TABLE 187. AFRICA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 188. AFRICA OPIOIDS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 189. AFRICA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 197. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 198. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 199. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
TABLE 200. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 201. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 202. ASIA-PACIFIC OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL OPIOIDS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 204. ASEAN OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. ASEAN OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2032 (USD MILLION)
TABLE 206. ASEAN OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2032 (USD MILLION)
TABLE 207. ASEAN OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 208. ASEAN OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 209. ASEAN OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 210. ASEAN OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 211. ASEAN OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 212. ASEAN OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 213. ASEAN OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
TABLE 214. ASEAN OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 215. ASEAN OPIOIDS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 216. ASEAN OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 217. GCC OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 218. GCC OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2032 (USD MILLION)
TABLE 219. GCC OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2032 (USD MILLION)
TABLE 220. GCC OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 221. GCC OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 222. GCC OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 223. GCC OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 224. GCC OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 225. GCC OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 226. GCC OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
TABLE 227. GCC OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 228. GCC OPIOIDS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 229. GCC OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 230. EUROPEAN UNION OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION OPIOIDS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 243. BRICS OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 244. BRICS OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2032 (USD MILLION)
TABLE 245. BRICS OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2032 (USD MILLION)
TABLE 246. BRICS OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 247. BRICS OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 248. BRICS OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 249. BRICS OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 250. BRICS OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 251. BRICS OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 252. BRICS OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
TABLE 253. BRICS OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 254. BRICS OPIOIDS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 255. BRICS OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 256. G7 OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 257. G7 OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2032 (USD MILLION)
TABLE 258. G7 OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2032 (USD MILLION)
TABLE 259. G7 OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 260. G7 OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 261. G7 OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 262. G7 OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 263. G7 OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 264. G7 OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 265. G7 OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
TABLE 266. G7 OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 267. G7 OPIOIDS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 268. G7 OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 269. NATO OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 270. NATO OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2032 (USD MILLION)
TABLE 271. NATO OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2032 (USD MILLION)
TABLE 272. NATO OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 273. NATO OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 274. NATO OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 275. NATO OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 276. NATO OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 277. NATO OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 278. NATO OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
TABLE 279. NATO OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 280. NATO OPIOIDS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 281. NATO OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 282. GLOBAL OPIOIDS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 283. UNITED STATES OPIOIDS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 284. UNITED STATES OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2032 (USD MILLION)
TABLE 285. UNITED STATES OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2032 (USD MILLION)
TABLE 286. UNITED STATES OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 287. UNITED STATES OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 288. UNITED STATES OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 289. UNITED STATES OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 290. UNITED STATES OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 291. UNITED STATES OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 292. UNITED STATES OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
TABLE 293. UNITED STATES OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 294. UNITED STATES OPIOIDS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 295. UNITED STATES OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)
TABLE 296. CHINA OPIOIDS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 297. CHINA OPIOIDS MARKET SIZE, BY OPIOID TYPES, 2018-2032 (USD MILLION)
TABLE 298. CHINA OPIOIDS MARKET SIZE, BY NATURAL OPIATES, 2018-2032 (USD MILLION)
TABLE 299. CHINA OPIOIDS MARKET SIZE, BY SEMI-SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 300. CHINA OPIOIDS MARKET SIZE, BY SYNTHETIC OPIOIDS, 2018-2032 (USD MILLION)
TABLE 301. CHINA OPIOIDS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 302. CHINA OPIOIDS MARKET SIZE, BY ORAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 303. CHINA OPIOIDS MARKET SIZE, BY PARENTERAL ADMINISTRATION, 2018-2032 (USD MILLION)
TABLE 304. CHINA OPIOIDS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 305. CHINA OPIOIDS MARKET SIZE, BY ANESTHESIA, 2018-2032 (USD MILLION)
TABLE 306. CHINA OPIOIDS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2032 (USD MILLION)
TABLE 307. CHINA OPIOIDS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 308. CHINA OPIOIDS MARKET SIZE, BY HEALTHCARE FACILITIES, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Opioids market report include:
  • AbbVie Inc.
  • Alvogen
  • Apotex Inc.
  • Biesterfeld SE
  • Daiichi Sankyo Company, Limited
  • Elite Pharmaceuticals, Inc.
  • Endo International plc
  • Fresenius SE & Co. KGaA
  • Hikma Pharmaceuticals PLC
  • Humanwell Healthcare (Group) Co., Ltd.
  • Indivior PLC
  • Johnson & Johnson Services, Inc.
  • Johnson Matthey Group
  • Kyowa Hakko Kirin Co. Ltd.
  • Mallinckrodt plc
  • Nutriband Inc.
  • Pfizer Inc.
  • Piramal Pharma Limited
  • Purdue Pharma L.P.
  • QuVa Pharma, Inc
  • SCA Pharma
  • Spectrum Chemical Mfg. Corp.
  • Teva Pharmaceutical Industries Ltd.
  • Tofigh Daru Research & Engineering Company
  • Verve HumanCare Laboratories
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages188
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 23.37 Billion
Forecasted Market Value ( USD ) by 2032 $ 29.96 Billion
Compound Annual Growth Rate4.2%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Opioid Induced Constipation Market - Global Forecast 2026-2032 - Product Image

Opioid Induced Constipation Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Acetaminophen-Opioid Combination Market - Global Forecast 2026-2032 - Product Image

Acetaminophen-Opioid Combination Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Opioid Analgesics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Image

Opioid Analgesics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • 210 Pages
  • Global
From
Opioid Dependence- Pipeline Insight, 2025 - Product Image

Opioid Dependence- Pipeline Insight, 2025

  • Clinical Trials
  • 80 Pages
  • Global
From
Opioid Use Disorder (OUD) Market Report 2025 - Product Image

Opioid Use Disorder (OUD) Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Opioids Market

Analgesics are a class of drugs used to relieve pain. Opioids are a type of analgesic that act on the nervous system to reduce the intensity of pain signals sent to the brain. Opioids are typically prescribed for moderate to severe pain, and are often used to treat chronic pain. They can be taken orally, injected, or applied topically. Opioids can be highly addictive and have a high potential for abuse, so they are typically prescribed with caution. Opioids are a major component of the analgesic market, and are used to treat a variety of conditions. Commonly prescribed opioids include oxycodone, hydrocodone, morphine, and codeine. Other analgesics, such as non-steroidal anti-inflammatory drugs (NSAIDs) and acetaminophen, are also used to treat pain. Companies in the opioids market include Purdue Pharma, Endo Pharmaceuticals, Teva Pharmaceuticals, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.